|
Match
|
Document |
Document Title |
|
|
7576084 |
Reverse-turn mimetics and method relating thereto
Conformationally constrained compounds that mimic the secondary structure of reverse-turn regions of biologically active peptides and proteins are disclosed. Such reverse-turn mimetic structures...
|
|
|
7566711 |
Reverse-turn mimetics and method relating thereto
Conformationally constrained compounds that mimic the secondary structure of reverse-turn regions of biologically active peptides and proteins are disclosed. Such reverse-turn mimetic structures...
|
|
|
7507734 |
Pyridazinone derivatives
Disclosed are compounds according to the general formula (I), where the definitions of the substituents X, R 1 and R 2 are detailed in the description, as well as their physiologically acceptable...
|
|
|
7473669 |
Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-triazin-6-ones, and their use as fungicides
This invention relates to substituted dihydrotriazinones, triazinones and related compounds, compositions comprising such compounds and an agronomically acceptable carrier, and the use thereof as...
|
|
|
7470689 |
4-benzimidazol-2-ylpyridazin-3-one derivatives
Disclosed are compounds of the general formula (I), where the definition of the substituents A, B, D, E, R 1 and R 2 are detailed in the description, and the physiologically tolerated salts...
|
|
|
7462615 |
Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
The present invention concerns new compounds of formula (I), their process of preparation and their therapeutic use.
|
|
|
7462614 |
Imidazotriazine compounds
The present invention provides compounds of formula (I):
wherein all variables are as defined herein, pharmaceutical compositions containing the same, processes for preparing the same and their...
|
|
|
7419978 |
Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors
Compounds having the formula (I),
and pharmaceutically acceptable salts, prodrugs, and solvates thereof, are useful as kinase inhibitors, wherein R, R 1 , R 2 , R 5 , R 6a , R 6b , J, K, X and...
|
|
|
7326475 |
Material for organic electroluminescent device, organic electroluminescent device, illuminating device and display
The present invention provides: an organic EL element exhibiting high luminance, a high external quantum efficiency and a long high temperature driving life at 50° C.; an illuminator and a display...
|
|
|
7317012 |
Bicyclic heterocycles as cannabinoind-1 receptor modulators
The present application describes compounds according to Formula I, pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional...
|
|
|
7253167 |
Tricyclic-heteroaryl compounds useful as kinase inhibitors
The present invention relates to compounds having the formula,
wherein, Q is optionally substituted aryl or heteroaryl, R 1 is hydrogen or C 1-4 alkyl, and R 2 , R 3 , R 4 and R 5 are...
|
|
|
7241763 |
3-furanyl analogs of toxoflavine as kinase inhibitors
The present invention concerns the compounds of formula
the N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein m, n, R 1 , R...
|
|
|
7202243 |
Substituted imidazotriazines
The invention relates to new substituted imidazotriazines, processes for their preparation and their use for the production of medicaments for the treatment and/or prophylaxis of cancer and...
|
|
|
7199121 |
Protein tyrosine phosphatase inhibitor
Use of a compound of formula (I):
wherein
each R, which are the same or different, is H or C 1 –C 6 alkyl, and X completes a ring which is a substituted triazine having one of the following...
|
|
|
7196095 |
(Pyrimidinyl) (phenyl) substituted fused heteroaryl p38 inhibiting and PKG kinase inhibiting compounds
Compounds of formula (I) and pharmaceutically acceptable salts thereof are useful in the treatment of cytokine mediated diseases such as arthritis and in the treatment and/or prevention of...
|
|
|
7176203 |
Imidazo-triazine derivatives as ligands for gaba receptors
A class of imidazo[1,2 b ][1,2,4]triazine derivatives, substituted at the 7-position by an optionally substituted five-membered or six-membered heteroaromatic ring, being selective ligands for GABA...
|
|
|
7122548 |
Triazolotriazine compounds and uses thereof
The present invention relates to compounds of the Formula (I), and their pharmaceutically acceptable salts. These compounds modulate the activity of c-Met and are therefore expected to be useful in...
|
|
|
7115602 |
Heterocycles 3
The invention relates to 7-(4-tert butyl-cyclohexyl)-imidazotriazinones, processes for their preparation and their use in medicaments, esp. for the treatment and/or prophylaxis of inflammatory...
|
|
|
7098207 |
Imidazotriazinones and the use thereof
Novel imidazotriazinones of general formula
a method for the production and the pharmaceutical use thereof are disclosed.
|
|
|
7087605 |
5-Ethyl-imidazotriazinones
The invention relates to novel 5-Ethyl-imidazotriazinones, processes for their preparation and their use in medicaments, esp. for the treatment and/or prophylaxis of inflammatory processes and/or...
|
|
|
7074790 |
5-ethylimidarotriazones
The invention relates to novel 5-ethyl-imidazotriazinones, processes for their preparation and their use in medicaments, esp. for the treatment and/or prophylaxis of inflammatory processes and/or...
|
|
|
7037910 |
Azabicyclic heterocycles as cannabinoid receptor modulators
The present application describes compounds according to Formula I, pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional...
|
|
|
7037909 |
Tetracyclic compounds as c-Met inhibitors
The present invention relates to compounds of the Formulae (I) and (II), wherein R 1 -R 10 and G are defined herein, and their pharmaceutically acceptable salts. These compounds modulate the...
|
|
|
7022847 |
Method for the production of 2-(2-ethoxyphenyl)-substituted imidazotriazinones
The invention relates to a method for the production of 2-phenyl-substituted imidazotriazinones of general formula (I), comprising the reaction of compounds of formula (II) with compounds of...
|
|
|
7005431 |
Imidazo-triazine derivatives as ligands for gaba receptors
A class of 7-phenylimidazo[1,2-b][1,2,4]triazine derivatives, substituted at the meta position of the phenyl ring by an optionally substituted aryl or heteroaryl group which is directly attached or...
|
|
|
6998483 |
Process for the preparation of sulphonamide-substituted imidazotriazinones
The present invention relates to a process for the preparation of sulphonamide-substituted imidazotriazinones of the general formula (I)
characterized in that compounds of the formula (II)
...
|
|
|
6998402 |
Substituted imidazotriazinones
The invention relates to novel substituted imidazotriazinones, to a method for their production and to the use thereof for producing medicaments, in particular to improve perception, powers of...
|
|
|
6984641 |
Carboline derivatives as PDE5 inhibitors
Selective inhibitors of cGMP-specific PDE, and use of the compounds and salts and solvates thereof as therapeutic agents, are disclosed.
|
|
|
6977261 |
Azaisoquinoline derivatives as matrix metalloproteinase inhibitors
This invention provides compounds defined by Formula I
or a pharmaceutically acceptable salt thereof,
wherein R 1 , Q, Y, R 2 , R 3 , R 4 , R 5 , and n are as defined in the specification....
|
|
|
6943163 |
7-Alkyl and cycloalkyl-substituted imidazotriazinones
The present invention relates to 7-alkyl- and cycloalkyl-substituted imidazotriazinones, to processes for their preparation and to their use as medicaments, in particular as inhibitors of...
|
|
|
6943158 |
Diazinopyrimidines
Compounds of formula I are p38 inhibitors:
or a pharmaceutically acceptable salt thereof,
wherein
R 1 is hydrogen or alkyl; R 2 alkyl, haloalkyl, aryl, aralkyl, heteroaryl,...
|
|
|
6936609 |
Imidazotriazines for use as phosphodiesterase inhibitors
The invention relates to new imidazotriazines, processes for their preparation, and their use for the production of medicaments for the treatment and/or prophylaxis of neurodegenerative disorders,...
|
|
|
6914060 |
Imidazotriazinone derivatives as ligands for GABA receptors
The present invention relates to imidazo[2,1-f]triazin-4-one analogues which are substituted in the 7-position by a substituted phenyl ring, being ligands for GABA A receptors and accordingly of...
|
|
|
6890922 |
2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
The 2-phenyl-substituted imidazotriazinones having short, unbranched alkyl radicals in the 9-position are prepared from the corresponding 2-phenyl-imidazotriazinones by chlorosulphonation and...
|
|
|
6878708 |
Imidazotriazinones and the use thereof
Novel imidazotriazinones of general formula (I), a method for the production and the pharmaceutical use thereof are disclosed.
|
|
|
6861427 |
Azabicyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinoline as 5-HT1A antagonists
Compounds of the formula
are useful for treating the cognitive deficits due to aging, stroke, head trauma, Alzheimer's disease or other neurodegenerative diseases, or schizophrenia, and are...
|
|
|
6818641 |
Arthropodicidal carboxanilides
Compounds of Formula (I), and their N-oxides and agriculturally suitable salts, are disclosed which are useful as arthropodicides wherein A is H; E is H or C 1 -C 3 alkyl; or A and E can be taken...
|
|
|
6797710 |
Heterocyclic derivatives and their use as antithrombotic agents
The present invention relates to antithrombotic compounds comprising the group Q, Q having formula (I), wherein the substructure (i) is a structure selected from (a, b and c), wherein X is O or S;...
|
|
|
6794387 |
Pharmaceutically active compounds
Compounds of general formula (I): wherein R 1 , R 2 , R 3 , R 4 , X, Y and A have the meanings given herein which are useful in the curative and prophylactic treatment of a medical condition for...
|
|
|
6770645 |
Pharmaceutically active compounds
Compound of general formula I: wherein R 1 , R 2 , R 3 , R 4 , X, Y and R 5 have the meanings given herein which are useful in the curative and prophylactic treatment of a medical condition for...
|
|
|
6740654 |
Squaric acid derivatives
Squaric acid derivatives of formula (1) are described: wherein Het is an optionally substituted bicyclic fused ring heteroaromatic group; L 2 is a covalent bond or an atom or group —O—,...
|
|
|
6683081 |
Triazolotriazinones and the use thereof
The invention relates to novel triazolotriazinones of the general formula (I), to a method for their production and to the pharmaceutical use thereof.
|
|
|
6664398 |
Derivatives of erythromycin, their preparation process and their use as medicaments
A subject of the invention is the compounds of formula in which Y represents a hydrogen atom or a fluorine atom, n represents an integer comprised between 1 and 8, Z represents a hydrogen atom...
|
|
|
6642381 |
Pyrimido&lsqb 5,4-e&rsqb &lsqb 1,2,4&rsqb triazine-5,7-diamine compounds as protein tyrosine phosphatase inhibitors
The invention relates to pyrimido[5,4-e][1,2,4]triazine-5,7-diamine compounds which are useful for inhibiting protein tyrosine phosphatases, particularly PTP1B.
|
|
|
6586429 |
Tricyclic fused xanthine compounds and their uses
Novel tricyclic compounds are found to be useful for the treatment or prevention of symptoms or manifestations associated with diseases or disorders affected by cytokine intracellular signaling....
|
|
|
6573263 |
Substituted imidazotriazinones
The present invention relates to new substituted imidazotriazinones, processes for their preparation, and their use for the production of medicaments, in particular for improving perception,...
|
|
|
6541472 |
Compounds, compositions and methods for preventing and treating pestivirus infection and associated diseases
Triazinoindole derivatives are useful in the prophylaxis and treatment of pestivirus infections and diseases associated with pestivirus infections.
|
|
|
6541469 |
CRF receptor antagonists and methods relating thereto
CRF receptor antagonists are disclosed which have utility in the treatment of a variety of disorders, including the treatment of disorders manifesting hypersecretion of CRF in a warm-blooded...
|
|
|
6525056 |
Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (CRH) antagonists, useful for treating cns and stress-related disorders
Corticotropin releasing factor (CRF) antagonists of Formula (I): and their use in treating psychiatric disorders and neurological diseases, anxiety-related disorders, post-traumatic stress...
|
|
|
6525000 |
Method for producing anellated triazoles and new anellated triazoles and their use
A process for preparing fused triazoles of formula I where: X—X is C—O, C—S, C—SO, C—SO 2 , or C—NR 1 ; V is C═W 2 , R 1 R 2 C—C(═W 2 )— or C(═V 2 )—C(═W 2 ); W 1 , W 2...
|